Óscar Moralejo Lozano

Accuracy of the vedolizumab Clinical Decision Support Tool in Crohn's disease and its association with long-term persistence: A retrospective cohort study

Óscar Moralejo Lozano, Alberto Flores Camuñas, María Abanades Tercero, María Jesús Carrillo Ramos et autres

es (code pays fourni par la source)

Predictors of Steroid Failure and Outcomes of Rescue Therapy in Severe ICI-Induced Colitis: A Multicenter Study from GETECCU

Cristina Polo Cuadro, Marta Gascón Ruiz, Manuel Barreiro, Míriam Mañosa et autres

es (code pays fourni par la source)

Gender-related differences in structural pathways involving alcohol-related aggressive behaviors, family conflicts, and Cluster B personality disorders in substance use treatment: engagement, discharge, and readmissions

Daniel Dacosta-Sánchez, Bella M. González Ponce, Cinta Mancheño-Velasco, Marta Narváez-Camargo et autres

BACKGROUND: Gender-informed addiction care needs evidence on whether alcohol-related aggressive behaviors, family conflict and Cluster B pathology influence treatment differently for men and women. OBJECTIVE: To test gender-specific structural pathways associating years of problematic alcohol use, alcohol-related aggressive behaviors, partner conflict, child …

es (code pays fourni par la source)

RECURRENCIA POSQUIRÚRGICA DE LA ENFERMEDAD DE CROHN TRAS COLECTOMÍA: ESTUDIO RESECOL DEL GRUPO JOVEN DE GETECCU

Jose Luis Rueda García, Cristina Suárez Ferrer, Irene García de la Filia, Coral Rivas et autres

45 - IMPORTANCIA DEL DOLOR COMO MANIFESTACIÓN CLÍNICA EN LA EVOLUCIÓN Y LA GRAVEDAD DE LAS COLITIS INMUNOMEDIADAS GRAVES. DATOS DEL ESTUDIO REGIC DE GETECCU

Diego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz, Manuel Barreiro-de Acosta et autres

EFECTIVIDAD, DURABILIDAD, Y SEGURIDAD DE UPADACITINIB VERSUS RISANKIZUMAB TRAS FALLO A ANTI-TNF EN ENFERMEDAD DE CROHN: ESTUDIO U-PARIS DEL REGISTRO ENEIDA

Cristina Rubín de Célix, Alicia Granja, Marisa Iborra, Francisco Javier García Alonso et autres

31 - IMPORTANCIA DE LA SECUENCIA DE LOS DOS PRIMEROS TRATAMIENTOS BIOLÓGICOS EN LA ENFERMEDAD INFLAMATORIA INTESTINAL. ESTUDIO SECUTEM DEL REGISTRO ENEIDA

Diego Casas Deza, Carmen Yagüe Caballero, Ana Royo Esteban, Laura Figueras Panillo et autres

Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis

Diego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz, Manuel Barreiro-de Acosta et autres

Background: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy. They can cause immune-mediated colitis (IMC), a potentially severe adverse event. Current data on severe IMC (grade 3–4) are limited, particularly regarding clinical, endoscopic, and histological features. Methods: We conducted a multicenter, retrospective …

es (code pays fourni par la source)

P1100 Effectiveness of Risankizumab in Crohn’s Disease, our real-world experience: Clinical, Biochemical and Ultrasonographic responses. A single centre, observational, retrospective study

Óscar Moralejo Lozano, Vanessa Camila Jarrín Pesantes, María Abanades Tercero, Laurent Perez et autres

Abstract Background Risankizumab (RZB) is the first monoclonal antibody targeting IL-23 (p19 subunit) approved for moderate-to-severe Crohn’s disease (CD) patients. Clinical remission at week 12 has been reported 42-45% in the induction trials (ADVANCE, MOTIVATE), and up to 52% by week 52 …

es (code pays fourni par la source)

P1043 Efficacy of intravenous ustekinumab maintenance treatment in patients with Inflammatory Bowel Disease with partial response or loss of response to subcutaneous ustekinumab: A single centre, observational, retrospective study

Vanessa Camila Jarrín Pesantes, Óscar Moralejo Lozano, María Abanades Tercero, Leanne Perez et autres

Abstract Background Ustekinumab (UST) is approved for patients with moderate to severe Crohn’s Disease (CD) and Ulcerative Colitis (UC) who do not respond to standard treatment and/or anti-TNF. Clinical remission at week 52 is reported up to 53,1-43,8%; however, up to 35% …

es (code pays fourni par la source)

Rectal linitis plastica as the sole manifestation of breast cancer recurrence

Óscar Moralejo Lozano, Diego Muñoz López, Pablo Muñoz Gómez, Mayra Dalila Lindo Ricce et autres

We present the case of a 51-year-old woman with a history of invasive lobular breast adenocarcinoma in remission for six years following surgery, chemoradiotherapy, and hormone therapy. During follow-up, an asymptomatic elevation of CA 15-3 was detected. A CT scan revealed rectal …

es, us (code pays fourni par la source)

P-87 - EFICACIA Y SEGURIDAD DEL USO DE USTEKINUMAB INTRAVENOSO EN ENFERMEDAD INFLAMATORIA INTESTINAL

Vanessa Camila Jarrín Pesantes, Óscar Moralejo Lozano, María Abanades Tercero, Leanne Perez et autres